SUNPHARMA

HealthcareDrug Manufacturers - Specialty & GenericLarge Cap
Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited (SUNPHARMA) operates in the Healthcare sector as a Specialty & Generic Drug Manufacturer. The company develops, manufactures, and markets bran...

हिन्दी में

सन फार्मास्यूटिकल इंडस्ट्रीज लिमिटेड (SUNPHARMA) हेल्थकेयर सेक्टर में एक स्पेशलिटी और जेनेरिक ड्रग मैन्युफैक्चरर के रूप में काम करती है। कंपनी ब्रांडेड और जेनेरिक फॉर्मूलेशन, तथा ए...

₹1,760+0.01%1D
Previous trading day close · Data updates after market close
1W: -1.1%
1M: -5.6%
6M: +6.5%
1Y: +6.5%
67/100
AverageResearch Score
Market Cap
₹4.47L Cr
Large Cap
P/E Ratio
39.81
Fair
P/B Ratio
6.31
Premium
ROE
15.7%
Decent
ROCE
21.0%
Excellent
Debt / Equity
0.03
Low debt
Div. Yield
0.8%
Low yield
EV/EBITDA
23.63
Fair
52W Low: ₹1,583.7Current: ₹1,76052W High: ₹2,046.9
At 38% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
80/100
Growth
Revenue, EPS, profit growth
72/100
Valuation
PE, PB, EV/EBITDA vs sector
28/100
Risk
Debt levels, volatility, coverage
94/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
39.81(Fair)
Forward P/E
34.20(Premium)
P/B Ratio
6.31(Premium)
P/S Ratio
7.56(Expensive)
EV/EBITDA
23.63(Expensive)
Dividend Yield
0.8%
5Y CAGR
22.8%(High growth)
Revenue Growth
10.4%(Moderate)
Profitability
ROE
15.7%(Good)
ROCE
21.0%(Excellent)
ROA
12.3%(Efficient)
Net Margin
19.0%(High)
EBITDA Margin
30.4%
Financial Health
Debt to Equity
0.03(Low debt)
Current Ratio
2.89(Healthy)
Quick Ratio
2.33(Good)
Interest Coverage
45.61x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
37(Neutral)
RSI Exp (14)
26(Oversold)
MACD
-32.559(Bearish)
MACD Signal
-25.648
BB Position
2%(Lower band)
BB Width
7.97%(Normal)
ADX (14)
42.6(Strong trend)
Williams %R
-89.8(Oversold)
MFI (14)
36(Neutral)
CCI (20)
-160(Oversold)
Stoch %K
10(Oversold)
ATR (14)
33.77(Avg True Range)
OBV (M)
-4.4(Negative)
1W OBV Chg
-38.4%(Decreasing)
Rel Volume
0.73x(Normal)
Volatility
20.1%(Moderate)
Max DD 1Y
-19.0%(Resilient)
EMA 200
1827.1
EMA 50
1861.6
SMA 200
1808.7
vs SMA 50
-6.8%(Below SMA50)
vs SMA 200
-2.7%(Below SMA200)
Volume
13.46L
Avg Vol 3M
18.4L
Shareholding Pattern
Promoter
54.5%
High confidence
FII
15.9%
DII / MF
21.1%
Strong MF interest
Share SUNPHARMA
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.